These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 2403385

  • 1. Leukocyte alterations do not account for hepatitis induced by endotoxin or TNF alpha in galactosamine-sensitized mice.
    Tiegs G, Niehörster M, Wendel A.
    Biochem Pharmacol; 1990 Sep 15; 40(6):1317-22. PubMed ID: 2403385
    [Abstract] [Full Text] [Related]

  • 2. Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice.
    Tiegs G, Wolter M, Wendel A.
    Biochem Pharmacol; 1989 Feb 15; 38(4):627-31. PubMed ID: 2465008
    [Abstract] [Full Text] [Related]

  • 3. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice.
    Lehmann V, Freudenberg MA, Galanos C.
    J Exp Med; 1987 Mar 01; 165(3):657-63. PubMed ID: 3819645
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ornithine and histidine decarboxylase activities in mice sensitized to endotoxin, interleukin-1 or tumour necrosis factor by D-galactosamine.
    Endo Y, Kikuchi T, Nakamura M.
    Br J Pharmacol; 1992 Nov 01; 107(3):888-94. PubMed ID: 1472981
    [Abstract] [Full Text] [Related]

  • 6. Colchicine prevents tumor necrosis factor-induced toxicity in vivo.
    Tiegs G, Freudenberg MA, Galanos C, Wendel A.
    Infect Immun; 1992 May 01; 60(5):1941-5. PubMed ID: 1563785
    [Abstract] [Full Text] [Related]

  • 7. O(2)-Vinyl 1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate protection against D-galactosamine/endotoxin-induced hepatotoxicity in mice: genomic analysis using microarrays.
    Liu J, Saavedra JE, Lu T, Song JG, Clark J, Waalkes MP, Keefer LK.
    J Pharmacol Exp Ther; 2002 Jan 01; 300(1):18-25. PubMed ID: 11752092
    [Abstract] [Full Text] [Related]

  • 8. Similar cytokine but different coagulation responses to lipopolysaccharide injection in D-galactosamine-sensitized versus nonsensitized rats.
    Bahrami S, Redl H, Leichtfried G, Yu Y, Schlag G.
    Infect Immun; 1994 Jan 01; 62(1):99-105. PubMed ID: 8262655
    [Abstract] [Full Text] [Related]

  • 9. Studies on the hepatotoxicity of galactosamine/endotoxin or galactosamine/TNF in the perfused mouse liver.
    Wang JF, Wendel A.
    Biochem Pharmacol; 1990 Jan 15; 39(2):267-70. PubMed ID: 2302253
    [Abstract] [Full Text] [Related]

  • 10. Enhancement by galactosamine of lipopolysaccharide(LPS)-induced tumour necrosis factor production and lethality: its suppression by LPS pretreatment.
    Endo Y, Shibazaki M, Yamaguchi K, Kai K, Sugawara S, Takada H, Kikuchi H, Kumagai K.
    Br J Pharmacol; 1999 Sep 15; 128(1):5-12. PubMed ID: 10498828
    [Abstract] [Full Text] [Related]

  • 11. A link between extracellular reactive oxygen and endotoxin-induced release of tumour necrosis factor alpha in vivo.
    Neihörster M, Inoue M, Wendel A.
    Biochem Pharmacol; 1992 Mar 03; 43(5):1151-4. PubMed ID: 1554388
    [Abstract] [Full Text] [Related]

  • 12. Hematologic interactions of endotoxin, tumor necrosis factor alpha (TNF alpha), interleukin 1, and adrenal hormones and the hematologic effects of TNF alpha in Corynebacterium parvum-primed rats.
    Ulich TR, del Castillo J, Ni RX, Bikhazi N.
    J Leukoc Biol; 1989 Jun 03; 45(6):546-57. PubMed ID: 2786048
    [Abstract] [Full Text] [Related]

  • 13. Protection by sinomenine against endotoxin-induced fulminant hepatitis in galactosamine-sensitized mice.
    Kondo Y, Takano F, Yoshida K, Hojo H.
    Biochem Pharmacol; 1994 Aug 30; 48(5):1050-2. PubMed ID: 8093093
    [Abstract] [Full Text] [Related]

  • 14. Y-40138, a multiple cytokine production modulator, protects against D-galactosamine and lipopolysaccharide-induced hepatitis.
    Fukuda T, Mogami A, Tanaka H, Yoshikawa T, Hisadome M, Komatsu H.
    Life Sci; 2006 Jul 24; 79(9):822-7. PubMed ID: 16626762
    [Abstract] [Full Text] [Related]

  • 15. Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha.
    Görgen I, Hartung T, Leist M, Niehörster M, Tiegs G, Uhlig S, Weitzel F, Wendel A.
    J Immunol; 1992 Aug 01; 149(3):918-24. PubMed ID: 1378868
    [Abstract] [Full Text] [Related]

  • 16. Protective effect of baicalin against lipopolysaccharide/D-galactosamine-induced liver injury in mice by up-regulation of heme oxygenase-1.
    Wan JY, Gong X, Zhang L, Li HZ, Zhou YF, Zhou QX.
    Eur J Pharmacol; 2008 Jun 10; 587(1-3):302-8. PubMed ID: 18420187
    [Abstract] [Full Text] [Related]

  • 17. Melatonin attenuates lipopolysaccharide (LPS)-induced apoptotic liver damage in D-galactosamine-sensitized mice.
    Wang H, Xu DX, Lv JW, Ning H, Wei W.
    Toxicology; 2007 Jul 31; 237(1-3):49-57. PubMed ID: 17602819
    [Abstract] [Full Text] [Related]

  • 18. LPS challenge in D-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock.
    Mignon A, Rouquet N, Fabre M, Martin S, Pagès JC, Dhainaut JF, Kahn A, Briand P, Joulin V.
    Am J Respir Crit Care Med; 1999 Apr 31; 159(4 Pt 1):1308-15. PubMed ID: 10194182
    [Abstract] [Full Text] [Related]

  • 19. Protective Effects of Sesquiterpenoids from the Root of Panax ginseng on Fulminant Liver Injury Induced by Lipopolysaccharide/d-Galactosamine.
    Wang W, Zhang Y, Li H, Zhao Y, Cai E, Zhu H, Li P, Liu J.
    J Agric Food Chem; 2018 Jul 25; 66(29):7758-7763. PubMed ID: 29974747
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.